Neil Ashweek

USPTO Granted Patents = 24 (Patent Applications = 7)

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 68(Granted Patents)

Location History:

Escondido, CA (US) (2012 - 2021)
San Diego, CA (US) (2011 - 2023)

Company Filing History:

19 out of 120

Neurocrine Biosciences, Inc.

patents

6 out of 1,535

Boehringer Ingelheim International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421193 - GPR52 modulators and methods of use (2025-09-23),

2. 12383536 - CRF receptor antagonists and methods of use (2025-08-12),

3. 11713324 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2023-08-01),

4. 11053242 - [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto (2021-07-06),

5. 11021449 - Substituted triazoles and methods relating thereto (2021-06-01),

6. 10941159 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2021-03-09),

7. 10738017 - Substituted triazoles and methods relating thereto (2020-08-11),

8. 10336769 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2019-07-02),

9. 10138214 - Substituted triazoles and methods relating thereto (2018-11-27),

10. 9988382 - [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto (2018-06-05),

11. 9926308 - N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof (2018-03-27),

12. 9718789 - Substituted triazoles and methods relating thereto (2017-08-01),

13. 9714246 - [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto (2017-07-25),

14. 9469631 - N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof (2016-10-18),

15. 9422310 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2016-08-23),

Title: Neil Ashweek: Pioneering Innovator in Pharmacology

Introduction: Neil Ashweek, a visionary inventor based in Escondido, CA, is renowned for his relentless pursuit of innovation in the field of pharmacology. With 22 patents to his name, Ashweek's commitment to pushing boundaries has established him as a true luminary in the world of inventions.

Latest Patents: Ashweek's latest patents showcase his groundbreaking work in pharmacology. One notable patent focuses on Gonadotropin-releasing hormone receptor antagonists, offering novel treatment options for sex-hormone related conditions in both men and women. Another patent highlights his contributions to the field with compounds inhibiting the vesicular monoamine transporter 2 (VMAT2), a vital breakthrough in the treatment of hyperkinetic disorders.

Career Highlights: Throughout his illustrious career, Ashweek has made significant contributions to leading pharmaceutical companies such as Neurocrine Biosciences, Inc. and Boehringer Ingelheim International GmbH. His innovative spirit and dedication to scientific advancement have left a lasting impact on the industry.

Collaborations: Ashweek has collaborated with esteemed professionals in the field, including Timothy Richard Coon and Nicole Harriott. Together, they have worked on pioneering projects that have reshaped the landscape of pharmacology.

Conclusion: Neil Ashweek's visionary approach to innovation and his groundbreaking inventions in pharmacology cement his legacy as a true trailblazer. His unwavering commitment to pushing the boundaries of what is possible serves as an inspiration to future generations of inventors, ensuring that his impact on the field will endure for years to come.

This text is generated by artificial intelligence and may not be accurate.